Vincasar PFS is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is Vincristine Sulfate.
| Product ID | 0703-4402_1ef63a7e-d056-4213-b48c-b2af2799b199 |
| NDC | 0703-4402 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Vincasar PFS |
| Generic Name | Vincristine Sulfate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2000-05-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA075493 |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | VINCRISTINE SULFATE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Vinca Alkaloid [EPC],Vinca Alkaloids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2000-05-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA075493 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-05-01 |
| Ingredient | Strength |
|---|---|
| VINCRISTINE SULFATE | 1 mg/mL |
| SPL SET ID: | 01cee93f-3ab9-44fa-8c9a-dd5958fd2db9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0703-4402 | Vincasar PFS | vinCRIStine sulfate |
| 0703-4412 | Vincasar PFS | vinCRIStine sulfate |
| 20536-322 | Marqibo | Vincristine Sulfate |
| 72893-008 | Marqibo | Vincristine Sulfate |
| 61703-309 | VinCRIStine Sulfate | VINCRISTINE SULFATE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VINCASAR PFS 73688998 1491918 Live/Registered |
ERBAMONT INC. 1987-10-19 |